Abstract Prizes 2012

Abstract Prizes 2012 Clinical Research

First prize: T. Henopp, et al, Germany. Genetic Alterations in Glucagon Cell Adenomatosis

Second prize: S. Partelli, et al, Italy. Pattern and Clinical Predictors of Lymph Node Involvement in Pancreatic Neuroendocrine Tumors (PanNETs)

Third prize: V. Bernard, et al, France. Efficacy of Everolimus in Patients with Metastatic Insulinomas and Refractory Hypoglycemia: for the French Group of Endocrine Tumors (GTE-Renaten)

 

Abstract Prizes 2012 Basic science related to cancer biology

First prize: D. Swarts, et al, The Netherlands. Genome-Wide Expression Profiling Reveals Downregulation of OTP and CD44 and Upregulation of RET as Indicators of Poor Prognosis in Lung Carcinoids

Second prize: C. Thirwell, et al, United Kingdom. The First Neuroendocrine Tumor Methylome Using Methylation-Specific Immunoprecipitation Followed by Second Generation Sequencing – MeDIP-seq

Third prize: M. Palazzo, et al, France. Orexins Exert a Pro-Apoptotic Effect on Neuroendocrine Tumors (NETs) in an Ex Vivo Culture Model of Tissue Slices

Close
Notice
Important Notice:

In preparation of the upcoming ENETS Barcelona 2018 Annual Conference, we have discovered in the world wide web at least one professional entity suggestive of possessing an ENETS mandate for conference registrations. Therefore, we must inform you that 100% of all conference participants are registered through ENETS official website www.enets.org and http://enetsconference.org/. There are no further options to validly register for Barcelona 2018 (or for any other ENETS event).

Please stay away from fraudulent scams abusing the ENETS acronym to register – and charge you above official ENETS conference fees! Such entities, against whom ENETS presses criminal charges, are neither authorized, nor commissioned nor instructed by ENETS to make such representations.